Design Challenge: A Chat with Our Professor of Health Design

Peter Jones may have a common name, but he’s a rare animal. He’s one of the few academic design experts focusing specifically on the user experience in healthcare. And we are delighted to welcome him this year as one of our expert judges for the 2…

SOURCE: Healthline RSS Feed – Read entire story here.

An Artificial Pancreas Clinical Trial – On Candid Camera! In January, I met with Dr. Ed Damiano, one of the co-investigators at Boston University studying the artificial pancreas trials in humans. At the end of our conversation, he invited me to come up to Boston to check out one of the experiments. The ......
Basal Testing: A New Kind of Torture Just when I thought I'd experienced every indignity and inconvenience this disease could dish up, along comes basal testing.I've had the Big D for almost seven years now, and I've always been told never to skip meals (a good thing too, because I n......
A Techie Type 1 Reviews the New Medtronic "Revel" Insulin Pump + CGM System Technology blogger and Type 1 diabetic Scott Hanselman works for Microsoft, and is quite famous in software developer circles. As it happens, he's been wearing the brand new "Revel" combo Insulin Pump and Continuous Glucose Monitor (CGM) system f......
Ask D’Mine: Sleazy Advertising, Insulin Embarrassment Welcome back to our spankin' new diabetes advice column, Ask D'Mine. We just kicked off this series last week, and we're already getting lots of queries - so thank you, Curious PWDs! As a reminder: This is a place to send all your quirky or potent......
Tolerx: Attacking the Cause of Type 1 Diabetes in People (Not Mice) If you can still get excited about diabetes research headlines, then here's some exciting news coming out of Cambridge, Mass, this week: Tolerx, a life sciences company, has reported they are in Phase 3 clinical trials for a new treatment of type ......